pFLAG-CMV-hErk1 Citations (9)
Originally described in: cobb lab plasmidsUnpublished
Articles Citing pFLAG-CMV-hErk1
| Articles |
|---|
| Fibulin-5 inhibits Wnt/beta-catenin signaling in lung cancer. Chen X, Song X, Yue W, Chen D, Yu J, Yao Z, Zhang L. Oncotarget. 2015 Jun 20;6(17):15022-34. PubMed |
| The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress. Oh SE, Park HJ, He L, Skibiel C, Junn E, Mouradian MM. Redox Biol. 2018 Oct;19:62-73. doi: 10.1016/j.redox.2018.07.021. Epub 2018 Aug 3. PubMed |
| Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1. Sabbir MG. J Steroid Biochem Mol Biol. 2019 Jul;191:105376. doi: 10.1016/j.jsbmb.2019.105376. Epub 2019 May 5. PubMed |
| N-cadherin-regulated FGFR ubiquitination and degradation control mammalian neocortical projection neuron migration. Kon E, Calvo-Jimenez E, Cossard A, Na Y, Cooper JA, Jossin Y. Elife. 2019 Oct 2;8. pii: 47673. doi: 10.7554/eLife.47673. PubMed |
| Negative MAPK-ERK regulation sustains CIC-DUX4 oncoprotein expression in undifferentiated sarcoma. Lin YK, Wu W, Ponce RK, Kim JW, Okimoto RA. Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20776-20784. doi: 10.1073/pnas.2009137117. Epub 2020 Aug 11. PubMed |
| Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma. Qu H, Song X, Song Z, Jiang X, Gao X, Bai L, Wu J, Na L, Yao Z. Cancer Cell Int. 2020 Dec 9;20(1):592. doi: 10.1186/s12935-020-01693-y. PubMed |
| TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination. Zhu G, Herlyn M, Yang X. Nat Cell Biol. 2021 Sep;23(9):978-991. doi: 10.1038/s41556-021-00732-8. Epub 2021 Sep 8. PubMed |
| Eukaryotic initiation factor 6 regulates mechanical responses in endothelial cells. Keen AN, Payne LA, Mehta V, Rice A, Simpson LJ, Pang KL, Del Rio Hernandez A, Reader JS, Tzima E. J Cell Biol. 2022 Feb 7;221(2). pii: 212961. doi: 10.1083/jcb.202005213. Epub 2022 Jan 13. PubMed |
| Alzheimer's disease: Ablating single master site abolishes tau hyperphosphorylation. Stefanoska K, Gajwani M, Tan ARP, Ahel HI, Asih PR, Volkerling A, Poljak A, Ittner A. Sci Adv. 2022 Jul 8;8(27):eabl8809. doi: 10.1126/sciadv.abl8809. Epub 2022 Jul 6. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.